Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.
Sánchez-Martínez D, Lanuza PM, Gómez N, Muntasell A, Cisneros E, Moraru M, Azaceta G, Anel A, Martínez-Lostao L, Villalba M, Palomera L, Vilches C, García Marco JA, Pardo J.
Sánchez-Martínez D, et al. Among authors: vilches c.
Front Immunol. 2016 Oct 27;7:454. doi: 10.3389/fimmu.2016.00454. eCollection 2016.
Front Immunol. 2016.
PMID: 27833611
Free PMC article.